Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis

被引:25
作者
Pereira, Ivanio [1 ]
Laurindo, Ieda [2 ]
Burlingame, Rufus [3 ]
Anjos, Lisiane [1 ]
Viana, Vilma [2 ]
Leon, Elaine [2 ]
Vendramini, Margareth [2 ]
Borba, Eduardo [2 ]
机构
[1] Univ Fed Santa Catarina, Div Rheumatol, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Sao Paulo, Div Rheumatol, Sao Paulo, Brazil
[3] Inova Diagnost Inc, San Diego, CA USA
关键词
rheumatoid arthritis; atherosclerosis; autoantibody; antiphospholipid; anticardiolipin; anti-beta2-glycoprotein; 1; heat shock protein; lipoprotein lipase;
D O I
10.1016/j.jbspin.2008.01.022
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Many questions remain unanswered about premature atherosclerosis in rheumatoid arthritis (RA). Besides inflammation, some studies have suggested the role of autoantibodies on its pathogenesis. Objective: The aim of this study was to investigate the presence of antibodies against phospholipids, beta2-glycoproteinl (beta2-gpl), lipoprotein lipase, and heat shock proteins (Hsp) in RA patients and to evaluate their possible association with subclinical carotid atherosclerosis. Methods: Seventy-one RA patients and 53 age- and sex-matched controls were selected to perform anticardiolipin antibodies (aCL) (IgG and IgM), anti-beta2-gpl (IgG, IgM, and IgA), anti-lipoprotein lipase (anti-LPL), anti-Hsp 60, and anti-Hsp 65 by ELISA tests. Intima-medial thickness (IMT) of common carotid and presence of plaques were assessed by high-resolution B-mode ultrasonography. Exclusion criteria were smoking, diabetes, and arterial hypertension. Lipoproteins, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and fibrinogen levels, as well as health assessment questionnaire (HAQ) and disease activity score (DAS) 28 were also evaluated. Results: Age (48.93 +/- 12.31 vs. 45.37 +/- 9.37 years; p = 0.20) and body mass index (BMI) (p = 0.69) were similar in RA and controls, as well as female gender (p = 0.56). The mean IMT was similar between RA and controls (0. 721 +/- 0.16 vs. 0.667 +/- 0.14 turn, p = 0.07) but the frequency of plaques was higher in RA (14.1% vs. 1.9%; p = 0.02). In RA patients, IMT measurements did not differ according to the presence or absence of these antibodies: IgG aCL (0.62 +/- 0.64 vs. 0.72 +/- 0.17 mm, p = 0.24), IgM aCL (0.65 +/- 0.79 vs. 0.73 +/- 0.17 mm, p = 0.33), anti-Hsp 60 (0.78 +/- 0.20 vs. 0.71 +/- 0.16 mm, p = 0.27), anti-Hsp 65 (0.73 +/- 0.16 vs. 0.72 +/- 0.17 mm, p = 0.77), IgG anti-beta2-gpl (0.73 +/- 0.16 vs. 0.71 +/- 0.17 mm, p = 0.72), and anti-CCP (0.71 +/- 0.16 vs. 0.76 +/- 0.20 mm, p = 0.36). In addition, IMT did not correlate with antibodies titers: IgG aCL (r = -0.09, p = 0.47), IgM aCL (r = - 0.15, p = 0.21), anti-Hsp 60 (r = 0.10, p = 0.42), anti-Hsp 65 (r = 0.05, p = 0.69), IgG anti-beta2-gpl (r = - 0.07, p = 0.57), IgM anti-beta2-gpl (r = - 0.05, p = 0.69), IgA anti-beta2-gpl (r = 0.03, p = 0.79), and anti-CCP (r = - 0.07, p = 0.57). RA patients with plaques had a significantly higher age compared to those without plaques (p = 0.001), as well as higher mean IMT (p < 0.001), total cholesterol (p = 0.001), and LDL (p = 0.003). Conclusions: In RA a clear association between all autoantibodies studied herein and increased IMT or presence of plaques was not observed. The great prevalence of carotid atherosclerosis in RA was related to age, total and LDL cholesterol, as identified in normal population. (c) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:416 / 421
页数:6
相关论文
共 47 条
[1]
Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis: A controlled study [J].
Abu-Shakra, M ;
Polychuck, I ;
Szendro, G ;
Bolotin, A ;
Jonathan, BS ;
Flusser, D ;
Buskila, D ;
Sukenik, S .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (01) :18-23
[2]
Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies [J].
Ames, PRJ ;
Margarita, A ;
Alves, JD ;
Tommasino, C ;
Iannaccone, L ;
Brancaccio, V .
LUPUS, 2002, 11 (04) :208-214
[3]
Cardiovascular disease in rheumatoid arthritis:: Single-center hospital-based cohort study in France [J].
Assous, Noemie ;
Touze, Emmanuel ;
Meune, Christophe ;
Kahan, Andre ;
Allanore, Yannick .
JOINT BONE SPINE, 2007, 74 (01) :66-72
[4]
Barth JD, 2002, AM J CARDIOL, V89, p32B
[5]
Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14
[6]
BUCOLO G, 1975, CLIN CHEM, V21, P420
[7]
Burian K, 2001, CIRCULATION, V103, P1503
[8]
Anti-lipoprotein lipase antibodies -: A new player in the complex atherosclerotic process in systemic lupus erythematosus? [J].
de Carvalho, JF ;
Borba, EF ;
Viana, VST ;
Bueno, C ;
Leon, EP ;
Bonfá, E .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3610-3615
[9]
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects [J].
del Rincón, I ;
Williams, K ;
Stern, MP ;
Freeman, GL ;
O'Leary, DH ;
Escalante, A .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1833-1840
[10]
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam study [J].
del Sol, AI ;
Moons, KGM ;
Hollander, M ;
Hofman, A ;
Koudstaal, PJ ;
Grobbee, DE ;
Breteler, MMB ;
Witteman, JCM ;
Bots, ML .
STROKE, 2001, 32 (07) :1532-1538